PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjLink to Publisher's site
 
BMJ. 1995 July 29; 311(7000): 292.
PMCID: PMC2550360

Potentiation of warfarin by interferon.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (279K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990 Jul 19;323(3):147–152. [PubMed]
  • Renton KW, Singh G, Stebbing N. Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450. Biochem Pharmacol. 1984 Dec 1;33(23):3899–3902. [PubMed]
  • Okuno H, Kitao Y, Takasu M, Kano H, Kunieda K, Seki T, Shiozaki Y, Sameshima Y. Depression of drug metabolizing activity in the human liver by interferon-alpha. Eur J Clin Pharmacol. 1990;39(4):365–367. [PubMed]
  • Williams SJ, Baird-Lambert JA, Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet. 1987 Oct 24;2(8565):939–941. [PubMed]
  • Okuno H, Takasu M, Kano H, Seki T, Shiozaki Y, Inoue K. Depression of drug-metabolizing activity in the human liver by interferon-beta. Hepatology. 1993 Jan;17(1):65–69. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group